The standard treatment for patients with GBM includes surgical resection, radiation, and chemotherapy with temozolomide (TMZ); additional Avastin (bevacizumab) (antiangiogenesis) or gefitinib can be used to interrupt epidermal growth factor receptor (EGFR) signaling. This evidence concerns the gene EGFR and glioblastoma.